Atkisson Erik 4

4 · Eiger BioPharmaceuticals, Inc. · Filed Oct 1, 2021

Insider Transaction Report

Form 4
Period: 2021-09-30
Atkisson Erik
GC & Chief Compliance Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-09-30+180,000180,000 total
    Exercise: $6.68Exp: 2031-09-29Common Stock (180,000 underlying)
Footnotes (1)
  • [F1]The option vests as follows: 25% of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of September 20, 2021, with the remaining shares to vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4